Exact Mass: 517.3046228000001
Exact Mass Matches: 517.3046228000001
Found 500 metabolites which its exact mass value is equals to given mass value 517.3046228000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mycalamide B
C25H43NO10 (517.2886818000001)
Terpendole K
An organic heteroheptacyclic compound isolated from Albophoma yamanashiensis and has been shown to exhibit inhibitory activity against acyl-CoA:cholesterol acyltransferase.
LysoPC(18:3(9Z,12Z,15Z)/0:0)
LysoPC(18:3(9Z,12Z,15Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:3(9Z,12Z,15Z)), in particular, consists of one chain of a-linolenic acid at the C-1 position. The a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
LysoPC(18:3(6Z,9Z,12Z)/0:0)
LysoPC(18:3(6Z,9Z,12Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:3(6Z,9Z,12Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position. The g-linolenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(18:3(6Z,9Z,12Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:3(6Z,9Z,12Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position. The g-linolenic acid moiety is derived from animal fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
Retapamulin
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It was approved by the United States Food and Drug Administration in April 2007 for the treatment of bacterial skin infections such as impetigo. It is marketed as an ointment under the name brand Altabax. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
1-Hydroxy-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine
12-O-[(2S)-N,N-dimethyl-3-methylbutanoyl]-4-deoxyphorbol 13-acetate|N,N-dimethyl-12-(S-valinoyl)-13-acetyl-4alpha-4-deoxyphorbol
Lys Gln Asp Lys
Arg Gln Ser Lys
Thr Arg Ile Glu
Thr Ile Glu Arg
Asn Lys Glu Lys
Ser His Phe Lys
C24H35N7O6 (517.2648690000001)
Arg Thr Ile Glu
Retapamulin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
1-(9Z,12Z,15Z-Octadecatrienoyl)-2-hydroxy-sn-glycero-3-phosphocholine
Ala His Lys Tyr
C24H35N7O6 (517.2648690000001)
Ala His Tyr Lys
C24H35N7O6 (517.2648690000001)
Ala Lys His Tyr
C24H35N7O6 (517.2648690000001)
Ala Lys Asn Trp
C24H35N7O6 (517.2648690000001)
Ala Lys Trp Asn
C24H35N7O6 (517.2648690000001)
Ala Lys Tyr His
C24H35N7O6 (517.2648690000001)
Ala Asn Lys Trp
C24H35N7O6 (517.2648690000001)
Ala Asn Trp Lys
C24H35N7O6 (517.2648690000001)
Ala Trp Lys Asn
C24H35N7O6 (517.2648690000001)
Ala Trp Asn Lys
C24H35N7O6 (517.2648690000001)
Ala Tyr His Lys
C24H35N7O6 (517.2648690000001)
Asp Lys Lys Lys
Asp Lys Lys Gln
Asp Lys Gln Lys
Asp Gln Lys Lys
Glu Glu Ile Lys
Glu Glu Lys Ile
Glu Glu Lys Leu
Glu Glu Leu Lys
Glu Ile Glu Lys
Glu Ile Lys Glu
Glu Ile Arg Thr
Glu Ile Thr Arg
Glu Lys Glu Ile
Glu Lys Glu Leu
Glu Lys Ile Glu
Glu Lys Lys Asn
Glu Lys Leu Glu
Glu Lys Asn Lys
Glu Leu Glu Lys
Glu Leu Lys Glu
Glu Leu Arg Thr
Glu Leu Thr Arg
Glu Asn Lys Lys
Glu Arg Ile Thr
Glu Arg Leu Thr
Glu Arg Thr Ile
Glu Arg Thr Leu
Glu Thr Ile Arg
Glu Thr Leu Arg
Glu Thr Arg Ile
Glu Thr Arg Leu
Phe Pro Arg Val
Phe Pro Val Arg
Phe Arg Pro Val
Phe Arg Val Pro
Phe Val Pro Arg
Phe Val Arg Pro
Gly Lys Lys Trp
Gly Lys Trp Lys
Gly Trp Lys Lys
His His Lys Pro
His His Pro Lys
His Lys His Pro
His Lys Pro His
His Pro His Lys
His Pro Lys His
Ile Glu Glu Lys
Ile Glu Lys Glu
Ile Glu Arg Thr
Ile Glu Thr Arg
Ile Ile Ser Trp
Ile Ile Trp Ser
Ile Lys Glu Glu
Ile Leu Ser Trp
Ile Leu Trp Ser
Ile Met Arg Val
C22H43N7O5S (517.3046228000001)
Ile Met Val Arg
C22H43N7O5S (517.3046228000001)
Ile Arg Glu Thr
Ile Arg Met Val
C22H43N7O5S (517.3046228000001)
Ile Arg Thr Glu
Ile Arg Val Met
C22H43N7O5S (517.3046228000001)
Ile Ser Ile Trp
Ile Ser Leu Trp
Ile Ser Trp Ile
Ile Ser Trp Leu
Ile Thr Glu Arg
Ile Thr Arg Glu
Ile Thr Val Trp
Ile Thr Trp Val
Ile Val Met Arg
C22H43N7O5S (517.3046228000001)
Ile Val Arg Met
C22H43N7O5S (517.3046228000001)
Ile Val Thr Trp
Ile Val Trp Thr
Ile Trp Ile Ser
Ile Trp Leu Ser
Ile Trp Ser Ile
Ile Trp Ser Leu
Ile Trp Thr Val
Ile Trp Val Thr
Lys Asp Lys Lys
Lys Asp Lys Gln
Lys Asp Gln Lys
Lys Glu Glu Ile
Lys Glu Glu Leu
Lys Glu Ile Glu
Lys Glu Lys Asn
Lys Glu Leu Glu
Lys Glu Asn Lys
Lys Gly Lys Trp
Lys Gly Trp Lys
Lys His His Pro
Lys His Pro His
Lys Ile Glu Glu
Lys Lys Asp Lys
Lys Lys Asp Gln
Lys Lys Glu Asn
Lys Lys Gly Trp
Lys Lys Lys Asp
Lys Lys Asn Glu
Lys Lys Gln Asp
Lys Lys Arg Ser
Lys Lys Ser Arg
Lys Lys Trp Gly
Lys Leu Glu Glu
Lys Asn Glu Lys
Lys Asn Lys Glu
Lys Asn Arg Thr
Lys Asn Thr Arg
Lys Pro His His
Lys Gln Lys Asp
Lys Gln Arg Ser
Lys Gln Ser Arg
Lys Arg Lys Ser
Lys Arg Asn Thr
Lys Arg Gln Ser
Lys Arg Ser Lys
Lys Arg Ser Gln
Lys Arg Thr Asn
Lys Ser Lys Arg
Lys Ser Gln Arg
Lys Ser Arg Lys
Lys Ser Arg Gln
Lys Thr Asn Arg
Lys Thr Arg Asn
Lys Trp Gly Lys
Lys Trp Lys Gly
Leu Glu Glu Lys
Leu Glu Lys Glu
Leu Glu Arg Thr
Leu Glu Thr Arg
Leu Ile Ser Trp
Leu Ile Trp Ser
Leu Lys Glu Glu
Leu Leu Ser Trp
Leu Leu Trp Ser
Leu Met Arg Val
C22H43N7O5S (517.3046228000001)
Leu Met Val Arg
C22H43N7O5S (517.3046228000001)
Leu Arg Glu Thr
Leu Arg Met Val
C22H43N7O5S (517.3046228000001)
Leu Arg Thr Glu
Leu Arg Val Met
C22H43N7O5S (517.3046228000001)
Leu Ser Ile Trp
Leu Ser Leu Trp
Leu Ser Trp Ile
Leu Ser Trp Leu
Leu Thr Glu Arg
Leu Thr Arg Glu
Leu Thr Val Trp
Leu Thr Trp Val
Leu Val Met Arg
C22H43N7O5S (517.3046228000001)
Leu Val Arg Met
C22H43N7O5S (517.3046228000001)
Leu Val Thr Trp
Leu Val Trp Thr
Leu Trp Ile Ser
Leu Trp Leu Ser
Leu Trp Ser Ile
Leu Trp Ser Leu
Leu Trp Thr Val
Leu Trp Val Thr
Met Ile Arg Val
C22H43N7O5S (517.3046228000001)
Met Ile Val Arg
C22H43N7O5S (517.3046228000001)
Met Leu Arg Val
C22H43N7O5S (517.3046228000001)
Met Leu Val Arg
C22H43N7O5S (517.3046228000001)
Met Arg Ile Val
C22H43N7O5S (517.3046228000001)
Met Arg Leu Val
C22H43N7O5S (517.3046228000001)
Met Arg Val Ile
C22H43N7O5S (517.3046228000001)
Met Arg Val Leu
C22H43N7O5S (517.3046228000001)
Met Val Ile Arg
C22H43N7O5S (517.3046228000001)
Met Val Leu Arg
C22H43N7O5S (517.3046228000001)
Met Val Arg Ile
C22H43N7O5S (517.3046228000001)
Met Val Arg Leu
C22H43N7O5S (517.3046228000001)
Asn Glu Lys Lys
Asn Lys Lys Glu
Asn Lys Arg Thr
Asn Lys Thr Arg
Asn Arg Lys Thr
Asn Arg Thr Lys
Asn Thr Lys Arg
Asn Thr Arg Lys
Pro Phe Arg Val
Pro Phe Val Arg
Pro His His Lys
Pro His Lys His
Pro Lys His His
Pro Arg Phe Val
Pro Arg Val Phe
Pro Val Phe Arg
Pro Val Arg Phe
Gln Asp Lys Lys
Gln Lys Asp Lys
Gln Lys Lys Asp
Gln Lys Arg Ser
Gln Lys Ser Arg
Gln Arg Lys Ser
Gln Arg Ser Lys
Gln Ser Lys Arg
Gln Ser Arg Lys
Arg Glu Ile Thr
Arg Glu Leu Thr
Arg Glu Thr Ile
Arg Glu Thr Leu
Arg Phe Pro Val
Arg Phe Val Pro
Arg Ile Glu Thr
Arg Ile Met Val
C22H43N7O5S (517.3046228000001)
Arg Ile Thr Glu
Arg Ile Val Met
C22H43N7O5S (517.3046228000001)
Arg Lys Lys Ser
Arg Lys Asn Thr
Arg Lys Gln Ser
Arg Lys Ser Lys
Arg Lys Ser Gln
Arg Lys Thr Asn
Arg Leu Glu Thr
Arg Leu Met Val
C22H43N7O5S (517.3046228000001)
Arg Leu Thr Glu
Arg Leu Val Met
C22H43N7O5S (517.3046228000001)
Arg Met Ile Val
C22H43N7O5S (517.3046228000001)
Arg Met Leu Val
C22H43N7O5S (517.3046228000001)
Arg Met Val Ile
C22H43N7O5S (517.3046228000001)
Arg Met Val Leu
C22H43N7O5S (517.3046228000001)
Arg Asn Lys Thr
Arg Asn Thr Lys
Arg Pro Phe Val
Arg Pro Val Phe
Arg Gln Lys Ser
Arg Ser Lys Lys
Arg Ser Lys Gln
Arg Ser Gln Lys
Arg Thr Glu Ile
Arg Thr Glu Leu
Arg Thr Lys Asn
Arg Thr Leu Glu
Arg Thr Asn Lys
Arg Val Phe Pro
Arg Val Ile Met
C22H43N7O5S (517.3046228000001)
Arg Val Leu Met
C22H43N7O5S (517.3046228000001)
Arg Val Met Ile
C22H43N7O5S (517.3046228000001)
Arg Val Met Leu
C22H43N7O5S (517.3046228000001)
Arg Val Pro Phe
Ser Ile Ile Trp
Ser Ile Leu Trp
Ser Ile Trp Ile
Ser Ile Trp Leu
Ser Lys Lys Arg
Ser Lys Gln Arg
Ser Lys Arg Lys
Ser Lys Arg Gln
Ser Leu Ile Trp
Ser Leu Leu Trp
Ser Leu Trp Ile
Ser Leu Trp Leu
Ser Gln Lys Arg
Ser Gln Arg Lys
Ser Arg Lys Lys
Ser Arg Lys Gln
Ser Arg Gln Lys
Ser Trp Ile Ile
Ser Trp Ile Leu
Ser Trp Leu Ile
Ser Trp Leu Leu
Thr Glu Ile Arg
Thr Glu Leu Arg
Thr Glu Arg Ile
Thr Glu Arg Leu
Thr Ile Arg Glu
Thr Ile Val Trp
Thr Ile Trp Val
Thr Lys Asn Arg
Thr Lys Arg Asn
Thr Leu Glu Arg
Thr Leu Arg Glu
Thr Leu Val Trp
Thr Leu Trp Val
Thr Asn Lys Arg
Thr Asn Arg Lys
Thr Arg Glu Ile
Thr Arg Glu Leu
Thr Arg Lys Asn
Thr Arg Leu Glu
Thr Arg Asn Lys
Thr Val Ile Trp
Thr Val Leu Trp
Thr Val Trp Ile
Thr Val Trp Leu
Thr Trp Ile Val
Thr Trp Leu Val
Thr Trp Val Ile
Thr Trp Val Leu
Val Phe Pro Arg
Val Phe Arg Pro
Val Ile Met Arg
C22H43N7O5S (517.3046228000001)
Val Ile Arg Met
C22H43N7O5S (517.3046228000001)
Val Ile Thr Trp
Val Ile Trp Thr
Val Leu Met Arg
C22H43N7O5S (517.3046228000001)
Val Leu Arg Met
C22H43N7O5S (517.3046228000001)
Val Leu Thr Trp
Val Leu Trp Thr
Val Met Ile Arg
C22H43N7O5S (517.3046228000001)
Val Met Leu Arg
C22H43N7O5S (517.3046228000001)
Val Met Arg Ile
C22H43N7O5S (517.3046228000001)
Val Met Arg Leu
C22H43N7O5S (517.3046228000001)
Val Pro Phe Arg
Val Pro Arg Phe
Val Arg Phe Pro
Val Arg Ile Met
C22H43N7O5S (517.3046228000001)
Val Arg Leu Met
C22H43N7O5S (517.3046228000001)
Val Arg Met Ile
C22H43N7O5S (517.3046228000001)
Val Arg Met Leu
C22H43N7O5S (517.3046228000001)
Val Arg Pro Phe
Val Thr Ile Trp
Val Thr Leu Trp
Val Thr Trp Ile
Val Thr Trp Leu
Val Trp Ile Thr
Val Trp Leu Thr
Val Trp Thr Ile
Val Trp Thr Leu
Trp Gly Lys Lys
Trp Ile Ile Ser
Trp Ile Leu Ser
Trp Ile Ser Ile
Trp Ile Ser Leu
Trp Ile Thr Val
Trp Ile Val Thr
Trp Lys Gly Lys
Trp Lys Lys Gly
Trp Leu Ile Ser
Trp Leu Leu Ser
Trp Leu Ser Ile
Trp Leu Ser Leu
Trp Leu Thr Val
Trp Leu Val Thr
Trp Ser Ile Ile
Trp Ser Ile Leu
Trp Ser Leu Ile
Trp Ser Leu Leu
Trp Thr Ile Val
Trp Thr Leu Val
Trp Thr Val Ile
Trp Thr Val Leu
Trp Val Ile Thr
Trp Val Leu Thr
Trp Val Thr Ile
Trp Val Thr Leu
PC(18:3/0:0)[U]
PC(18:3/0:0)
Linolenoyl lysolecithin
4-(dioctylamino)-4-(trifluoroacetyl) az
C30H42F3N3O (517.3279798000001)
[5-[[4-[2-[tert-butyl(dimethyl)silyl]oxyethyl]piperazin-1-yl]methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid
C26H44BN3O5Si (517.3143124000001)
(2-Hydroxy-3-octadeca-6,9,12-trienoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
(2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (5Z,8Z,11R,12E,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoate
(2S)-N-[(4S,4aR,6R,8S,8aR)-6-[(2S)-3-hydroxy-2-methoxypropyl]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-4-yl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
C25H43NO10 (517.2886818000001)
N5-2,4-diaminobutanoate-N1-citryl-N3-decanoyl-N3-hydroxy-1,3-diaminopropane
2-azaniumylethyl (2R)-3-hydroxy-2-{[(5Z,8Z,11R,12E,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoyl]oxy}propyl phosphate
3-cyclohexyl-1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
[(1S,2R,3S,4R,6R,7R,8R,14S)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl]acetate
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2-pyridinylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyridinecarboxamide
(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
N-[(5S,6R,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
3-cyclohexyl-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
3-cyclohexyl-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
3-cyclohexyl-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
5-hexynoic acid [(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] ester
[2-acetyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
(4E,8E)-3-hydroxy-2-(2-hydroxytridecanoylamino)tetradeca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxypentadec-9-enoyl]amino]dodec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)pentadeca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]tridec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]pentadec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxyhexadec-7-enoyl]amino]undec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(4E,8E)-3-hydroxy-2-(2-hydroxypentadecanoylamino)dodeca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(4E,8E)-3-hydroxy-2-(2-hydroxytetradecanoylamino)trideca-4,8-diene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] pentanoate
3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]undecane-1-sulfonic acid
C27H51NO6S (517.3436906000001)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]tetradec-4-ene-1-sulfonic acid
C27H51NO6S (517.3436906000001)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] propanoate
[2-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[2-hydroxy-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-hydroxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-2-hydroxy-3-[(6E,9E,12E)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-2-hydroxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)octadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxyheptadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(pentanoylamino)hexadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-acetamido-3-hydroxynonadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(heptanoylamino)-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(4E,8E,12E)-2-(hexanoylamino)-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
(2S)-N-[(4S,4aS,8S,8aR)-6-[(2S)-3-hydroxy-2-methoxypropyl]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-4-yl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
C25H43NO10 (517.2886818000001)
2-[(11R)-hydroxy-(5Z,8Z,12E,14Z)-icosatetraenoyl]-sn-glycero-3-phosphoethanolamine
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (11R)-hydroxy-(5Z,8Z,12E,14Z)-icosatetraenoyl.
phosphatidylethanolamine 20:3 zwitterion
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 20 carbons and 3 double bonds.
alpha-linolenoyl-sn-glycero-3-phosphocholine
An acyl-sn-glycero-3-phosphocholine in which the acyl group (with no specified position) is alpha-linolenoyl. Formula:C26H48NO7P.
lysophosphatidylcholine 18:3
An acyl-sn-glycero-3-phosphocholine in which the acyl group contains 18 carbons with 3 double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
lysophosphatidylcholine (18:3/0:0)
A lysophosphatidylcholine 18:3 in which the acyl group is located at position 1.
lysophosphatidylcholine (0:0/18:3)
A lysophosphatidylcholine 18:3 in which the acyl group is located at position 2.
2-[(11R)-hydroxy-(5Z,8Z,12E,14Z)-icosatetraenoyl]-sn-glycero-3-phosphoethanolamine zwitterion
A 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion obtained by transfer of a proton from the phosphate to the amino group of 2-(11R)-hydroxy-(5Z,8Z,12E,14Z)-icosatetraenoyl-sn-glycero-3-phosphoethanolamine; major species at pH 7.3.
1-alpha-linolenoyl-sn-glycero-3-phosphocholine
A PC(18:3/0:0) in which the 1-acyl group is specified as alpha-linolenoyl.
PE(21:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(20:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(17:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved